Targeting Glioma Stem Cells by Functional Inhibition of a Prosurvival OncomiR-138 in Malignant Gliomas

Cell Reports

Volumn 2, Issue 3, 2012, Pages 591-602

  Chan, Xin Hui Derryn ^a   Nama, Srikanth ^a   Gopal, Felicia ^a   Rizk, Pamela ^a   Ramasamy, Srinivas ^a   Sundaram, Gopinath ^a   Ow, Ghim Siong ^b   Ivshina, Anna Vladimirovna ^b   Tanavde, Vivek ^b   Haybaeck, Johannes ^c   Kuznetsov, Vladimir ^b   Sampath, Prabha ^a,d  

^a INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^b BIOINFORMATICS INSTITUTE   (Singapore)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; MICRORNA; MICRORNA 138; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURVIVAL; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GLIOBLASTOMA; GLIOMA STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING;

EID: 84866905323     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.07.012     Document Type: Article

References (53)

1. Amati B., Brooks M.W., Levy N., Littlewood T.D., Evan G.I., Land H. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 1993, 72:233-245.
2. Ayer D.E., Kretzner L., Eisenman R.N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 1993, 72:211-222.
3. Ball K.L., Lain S., Fâhraeus R., Smythe C., Lane D.P. Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1. Curr. Biol. 1997, 7:71-80.
4. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
5. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., Shi Q., McLendon R.E., Bigner D.D., Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006, 66:7843-7848.
6. Bottoni A., Piccin D., Tagliati F., Luchin A., Zatelli M.C., degli Uberti E.C. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J. Cell. Physiol. 2005, 204:280-285.
7. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
8. Campeau E., Ruhl V.E., Rodier F., Smith C.L., Rahmberg B.L., Fuss J.O., Campisi J., Yaswen P., Cooper P.K., Kaufman P.D. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 2009, 4:e6529.
9. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
10. Chong Y.K., Toh T.B., Zaiden N., Poonepalli A., Leong S.H., Ong C.E., Yu Y., Tan P.B., See S.J., Ng W.H., et al. Cryopreservation of neurospheres derived from human glioblastoma multiforme. Stem Cells 2009, 27:29-39.
11. Colorado P.C., Torre A., Kamphaus G., Maeshima Y., Hopfer H., Takahashi K., Volk R., Zamborsky E.D., Herman S., Sarkar P.K., et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 2000, 60:2520-2526.
12. Corsten M.F., Miranda R., Kasmieh R., Krichevsky A.M., Weissleder R., Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 2007, 67:8994-9000.
13. D'Urso P.I., D'Urso O.F., Storelli C., Mallardo M., Gianfreda C.D., Montinaro A., Cimmino A., Pietro C., Marsigliante S. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int. J. Oncol. 2012, 41:228-234.
14. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
15. Fan D.G., Zhao F., Ding Y., Wu M.M., Fan Q.Y., Shimizu K., Dohjima T., Nozawa S., Wakahara K., Ohno T., et al. BLCAP induces apoptosis in human Ewing's sarcoma cells. Exp. Biol. Med. (Maywood) 2011, 236:1030-1035.
16. Foong C.S., Ng F.S., Phong M., Toh T.B., Chong Y.K., Tucker-Kellogg G., Campbell R.M., Ang B.T., Tang C. Cryopreservation of cancer-initiating cells derived from glioblastoma. Front Biosci (Schol Ed) 2011, 3:698-708.
17. Gal H., Pandi G., Kanner A.A., Ram Z., Lithwick-Yanai G., Amariglio N., Rechavi G., Givol D. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. Biochem. Biophys. Res. Commun. 2008, 376:86-90.
18. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
19. Garden A.S., Maor M.H., Yung W.K., Bruner J.M., Woo S.Y., Moser R.P., Lee Y.Y. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother. Oncol. 1991, 20:99-110.
20. Godlewski J., Bronisz A., Nowicki M.O., Chiocca E.A., Lawler S. microRNA-451: a conditional switch controlling glioma cell proliferation and migration. Cell Cycle 2010, 9:2742-2748.
21. Guessous F., Zhang Y., Kofman A., Catania A., Li Y., Schiff D., Purow B., Abounader R. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 2010, 9:1031-1036.
22. Han S.H., Jeon J.H., Ju H.R., Jung U., Kim K.Y., Yoo H.S., Lee Y.H., Song K.S., Hwang H.M., Na Y.S., et al. VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 2003, 22:4035-4046.
23. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100:15178-15183.
24. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127.
25. Kim T.M., Huang W., Park R., Park P.J., Johnson M.D. A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res. 2011, 71:3387-3399.
26. Kobayashi N.R., Sui L., Tan P.S., Lim E.K., Chan J., Choolani M., Crook J.M. Modelling disrupted-in-schizophrenia 1 loss of function in human neural progenitor cells: tools for molecular studies of human neurodevelopment and neuropsychiatric disorders. Mol. Psychiatry 2010, 15:672-675.
27. Kondo M., Ji L., Kamibayashi C., Tomizawa Y., Randle D., Sekido Y., Yokota J., Kashuba V., Zabarovsky E., Kuzmin I., et al. Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells. Oncogene 2001, 20:6258-6262.
28. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
29. Lai C.P., Bechberger J.F., Naus C.C. Pannexin2 as a novel growth regulator in C6 glioma cells. Oncogene 2009, 28:4402-4408.
30. Lavon I., Zrihan D., Granit A., Einstein O., Fainstein N., Cohen M.A., Cohen M.A., Zelikovitch B., Shoshan Y., Spektor S., et al. Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro-oncol. 2010, 12:422-433.
31. Legler J.M., Ries L.A., Smith M.A., Warren J.L., Heineman E.F., Kaplan R.S., Linet M.S. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J. Natl. Cancer Inst. 1999, 91:1382-1390.
32. Li Y., Guessous F., Zhang Y., Dipierro C., Kefas B., Johnson E., Marcinkiewicz L., Jiang J., Yang Y., Schmittgen T.D., et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009, 69:7569-7576.
33. Liu D.P., Wang Y., Koeffler H.P., Xie D. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK. Int. J. Oncol. 2007, 30:865-871.
34. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
35. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
36. Malzkorn B., Wolter M., Liesenberg F., Grzendowski M., Stühler K., Meyer H.E., Reifenberger G. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2010, 20:539-550.
37. Motakis E., Ivshina A.V., Kuznetsov V.A. Data-driven approach to predict survival of cancer patients: estimation of microarray genes' prediction significance by Cox proportional hazard regression model. IEEE Eng. Med. Biol. Mag. 2009, 28:58-66.
38. Ng F.S., Toh T.B., Ting E.H., Koh G.R., Sandanaraj E., Phong M., Wong S.S., Leong S.H., Kon O.L., Tucker-Kellogg G., et al. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors. Clin. Cancer Res. 2012, 18:4122-4135.
39. Nyberg P., Xie L., Sugimoto H., Colorado P., Sund M., Holthaus K., Sudhakar A., Salo T., Kalluri R. Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor. Exp. Cell Res. 2008, 314:3292-3305.
40. Obernosterer G., Leuschner P.J., Alenius M., Martinez J. Post-transcriptional regulation of microRNA expression. RNA 2006, 12:1161-1167.
41. Papagiannakopoulos T., Shapiro A., Kosik K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008, 68:8164-8172.
42. Reynolds B.A., Rietze R.L. Neural stem cells and neurospheres-re-evaluating the relationship. Nat. Methods 2005, 2:333-336.
43. Rouault J.P., Falette N., Guéhenneux F., Guillot C., Rimokh R., Wang Q., Berthet C., Moyret-Lalle C., Savatier P., Pain B., et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 1996, 14:482-486.
44. Scherr M., Venturini L., Battmer K., Schaller-Schoenitz M., Schaefer D., Dallmann I., Ganser A., Eder M. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res. 2007, 35:e149.
45. * in glioblastoma stem cells. EMBO J. 2011, 30:4309-4322.
46. Shao S., Wang Y., Jin S., Song Y., Wang X., Fan W., Zhao Z., Fu M., Tong T., Dong L., et al. Gadd45a interacts with aurora-A and inhibits its kinase activity. J. Biol. Chem. 2006, 281:28943-28950.
47. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
48. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
49. Slack F.J., Weidhaas J.B. MicroRNAs as a potential magic bullet in cancer. Future Oncol. 2006, 2:73-82.
50. Wang A., Alimova I.N., Luo P., Jong A., Triche T.J., Wu L. Loss of CAK phosphorylation of RARalpha mediates transcriptional control of retinoid-induced cancer cell differentiation. FASEB J. 2010, 24:833-843.
51. Wang J., Wang H., Li Z., Wu Q., Lathia J.D., McLendon R.E., Hjelmeland A.B., Rich J.N. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One 2008, 3:e3769.
52. Yao J., Duan L., Fan M., Yuan J., Wu X. Overexpression of BLCAP induces S phase arrest and apoptosis independent of p53 and NF-kappaB in human tongue carcinoma : BLCAP overexpression induces S phase arrest and apoptosis. Mol. Cell. Biochem. 2007, 297:81-92.
53. Zheng H., Ying H., Yan H., Kimmelman A.C., Hiller D.J., Chen A.J., Perry S.R., Tonon G., Chu G.C., Ding Z., et al. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:427-437.